Search results for "bladder neoplasm"

showing 10 items of 158 documents

Teaching transurethral resection of the bladder: still a challenge?

2003

Abstract Objectives To report on our 2-year experience in teaching transurethral resection (TUR) of bladder tumors to five trainees. We analyzed their problems, as well as those of the teachers, and present our solutions. Methods Between April 2000 and March 2002, five residents and three members of the staff took part in a training program to teach TUR of the bladder. From a total of 692 patients with bladder tumors admitted for treatment to our department, 417 were selected for the study. These 417 had papillary tumors of small to medium size (maximum 25 mm in diameter). The mean patient age was 61 years (range 32 to 92) for men (n = 322; 77%) and 68.4 years (range 48 to 91) for women (n …

AdultMalemedicine.medical_specialtyUrologyUrinary BladdereducationPerforation (oil well)ResectionPostoperative ComplicationsPatient ageHumansMedicineProspective StudiesAgedAged 80 and overUrinary bladderSurgical approachbusiness.industryInternship and ResidencyMiddle AgedCarcinoma PapillarySurgerymedicine.anatomical_structureUrethraUrinary Bladder NeoplasmsGeneral SurgeryUrologic Surgical ProceduresEducation Medical ContinuingFemalebusinessTraining programComplicationProgram EvaluationUrology
researchProduct

Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer.

2006

PURPOSE: We assessed variability in the diagnostic performance of NMP22 for detecting recurrence and progression in patients with Ta, T1, and/or CIS transitional cell carcinoma of the bladder in a large international cohort. MATERIALS AND METHODS: NMP22 voided urine levels were measured in 2,871 patients who underwent office cystoscopy for monitoring previous stage Ta, T1 and/or CIS transitional cell carcinoma at 12 participating institutions. RESULTS: Patient characteristics varied considerably among institutions. Overall 1,045 patients (36.4%) had recurrent transitional cell carcinoma (range across institutions 13.6% to 54.3%). Median NMP22 was 5.5 U/ml (range across institutions 2.5 to 1…

AdultMalemedicine.medical_specialtyUrologyUrinary systemnuclear matrix protein 22Urologytumor markers biologicalBladder NeoplasmBiomarkers TumorMedicineHumansStage (cooking)bladderAgedGynecologyAged 80 and overCarcinoma Transitional CellUrinary bladderBladder cancermedicine.diagnostic_testbusiness.industryCarcinoma in situNuclear ProteinsReproducibility of ResultsCystoscopyMiddle Agedmedicine.diseasemedicine.anatomical_structureTransitional cell carcinomaUrinary Bladder NeoplasmsDisease Progressionbladder neoplasmFemaleNeoplasm Recurrence LocalbusinessThe Journal of urology
researchProduct

Computerized tomography: an unreliable method for accurate staging of bladder tumors in patients who are candidates for radical cystectomy.

1989

A total of 164 patients with bladder tumors underwent preoperative staging by computerized tomography. All patients were previously untreated, or had undergone only transurethral biopsy or resection of the tumor before computerized tomography. The post-cystectomy histological stage was compared to the preoperative computerized tomography stage. Computerized tomography accuracy according to the tumor, nodes and metastasis classification was only 32.3%, whereas overstaging was found in 39.6% and understaging in 28.1% of the cases. In untouched tumors or after transurethral resection computerized tomography accuracy demonstrated no significant difference. Only 2 of 19 true positive lymph nodes…

AdultMalemedicine.medical_specialtyUrologymedicine.medical_treatmentUrinary BladderMetastasisCystectomyBladder NeoplasmCarcinomaMedicineHumansStage (cooking)AgedNeoplasm StagingUrinary bladdermedicine.diagnostic_testbusiness.industryMiddle AgedTransurethral biopsymedicine.diseaseRadiation therapymedicine.anatomical_structureUrinary Bladder NeoplasmsEvaluation Studies as TopicFemaleRadiologybusinessTomography X-Ray ComputedThe Journal of urology
researchProduct

Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph nod…

2009

OBJECTIVE To investigate the associations between different overall or topographically restricted lymph node (LN) variables and cancer-specific survival (CSS) after radical cystectomy (RC) and extended LN dissection (LND) with curative intent in patients with LN-positive bladder cancer. PATIENTS AND METHODS Between 2001 and 2006, 152 patients had RC with standardized extended LND for bladder cancer with curative intent. Patients with positive LNs were stratified according to the median of the LN variables (LNs removed, number of positive LNs, LN density). CSS was related to overall and topographically restricted LN variables, e.g. different levels of LND, and relationships were tested by un…

AdultMalemedicine.medical_specialtyUrologymedicine.medical_treatmentUrologyCystectomyCystectomymedicineCarcinomaHumansLymph nodeAgedAged 80 and overCarcinoma Transitional CellBladder cancerbusiness.industryHazard ratioCancerMiddle AgedPrognosismedicine.diseaseConfidence intervalSurgeryTreatment Outcomemedicine.anatomical_structureUrinary Bladder NeoplasmsLymphatic MetastasisLymph Node ExcisionFemaleLymphadenectomyEpidemiologic MethodsbusinessBJU International
researchProduct

Radical cystectomy with or without adjuvant polychemotherapy for non-organ-confined transitional cell carcinoma of the urinary bladder: prognostic im…

1996

To analyze the effectiveness of adjuvant polychemotherapy after radical cystectomy for non-organ-confined transitional cell bladder cancer (Stages pT3b, pT4a, and/or pN1 or pN2).Of 166 consecutive patients undergoing cystectomy at two institutions from 1987 to 1993, 80 received adjuvant polychemotherapy with methotrexate, vinblastine, and cisplatin plus doxorubicin (MVAC) or epirubicin (MVEC), whereas 86 had cystectomy only. The patients were evaluated for relapse-free survival and length of progression-free interval on the basis of follow-up data obtained in 1995 and 1996.Kaplan-Meier analysis revealed a significantly higher progression-free rate for patients after adjuvant chemotherapy (P…

AdultMalemedicine.medical_specialtyUrologymedicine.medical_treatmentUrologyCystectomyDisease-Free SurvivalCystectomyAntineoplastic Combined Chemotherapy ProtocolsmedicineCarcinomaHumansProspective StudiesProspective cohort studyLymph nodeAgedAged 80 and overChemotherapyCarcinoma Transitional CellUrinary bladderbusiness.industryMiddle Agedmedicine.diseasePrognosisSurgerymedicine.anatomical_structureTransitional cell carcinomaUrinary Bladder NeoplasmsChemotherapy AdjuvantLymphatic MetastasisDisease ProgressionFemalebusinessAdjuvantFollow-Up StudiesUrology
researchProduct

Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study…

1995

A total of 83 patients with nonorgan-confined bladder cancer with or without lymph node metastases (tumor stages pT3b, pT4a and/or pN1, pN2) was evaluated in November 1993 for relapse-free and overall survival. All patients underwent radical cystectomy between 1987 and 1991, 38 underwent adjuvant polychemotherapy with methotrexate, vinblastine and cisplatin plus doxorubicin (M-VAC) or epirubicin (M-VEC). Of the 83 patients 49 had entered a prospective randomized trial comparing adjuvant to no adjuvant treatment. The protocol was activated in May 1987. Patient recruitment was concluded in December 1990 because an interim analysis of the 49 randomized patients revealed a significant prognosti…

AdultMalemedicine.medical_specialtyUrologymedicine.medical_treatmentUrologyCystectomyVinblastinelaw.inventionCystectomyRandomized controlled triallawAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansProspective StudiesSurvival rateAgedEpirubicinCarcinoma Transitional CellUrinary bladderBladder cancerbusiness.industryMiddle AgedInterim analysismedicine.diseaseCombined Modality TherapyVinblastineSurgerySurvival Ratemedicine.anatomical_structureMethotrexateUrinary Bladder NeoplasmsChemotherapy AdjuvantDoxorubicinLymphatic MetastasisFemaleCisplatinbusinessmedicine.drugEpirubicinThe Journal of urology
researchProduct

Advanced Bladder Cancer (Stages pT3b, pT4a, pN1 and pN2): Improved Survival after Radical Cystectomy and 3 Adjuvant Cycles of Chemotherapy. Results o…

1992

A total of 49 bladder cancer patients with tumor stages pT3b, pT4a and/or pelvic lymph node involvement without microscopic or macroscopic evidence of residual tumor was randomized into 2 comparative groups: the chemotherapy group was to receive 3 adjuvant cycles of methotrexate, vinblastine and cisplatin plus doxorubicin (M-VAC) or epirubicin (M-VEC) after radical cystectomy. The control group received no additional treatment. The protocol was activated in May 1987. Patient recruitment was concluded in December 1990 because an interim analysis of the 49 randomized patients revealed a significant prognostic advantage in favor of 26 patients randomized to the chemotherapy group compared to 2…

AdultMalemedicine.medical_specialtyUrologymedicine.medical_treatmentUrologyCystectomyVinblastinelaw.inventionCystectomyRandomized controlled triallawAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansProspective StudiesSurvival rateAgedEpirubicinChemotherapyBladder cancerbusiness.industryMiddle AgedInterim analysismedicine.diseaseSurgeryVinblastineSurvival RateMethotrexateUrinary Bladder NeoplasmsChemotherapy AdjuvantFemaleCisplatinbusinessmedicine.drugEpirubicinJournal of Urology
researchProduct

Gemcitabine and cisplatin for inoperable and/or metastatic biliary tree carcinomas: a multicenter phase II study of the Gruppo Oncologico dell'Italia…

2006

Background The aim of the study was to test the clinical efficacy and toxicity profile of gemcitabine (GEM) in combination with cisplatin (CDDP) in a series of patients affected by unresectable and/or metastatic biliary tree carcinoma (BTC) previously untreated with chemotherapy. Patients and methods Overall 38 consecutive patients who satisfied eligibility criteria (10 with gall-bladder carcinoma and 28 with bile duct carcinoma) were included in this phase II study. Median age was 61 years with median PS 1. Treatment included GEM 1000 mg/m2/week as 30 min i.v. on days 1 and 8, and CDDP 75–80 mg/m2 on day 1 with adequate hydration protocol and forced diuresis. Treatment was repeated every 3…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentPhases of clinical researchNeutropeniaDeoxycytidineGastroenterologyInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineCarcinomaHumansAgedChemotherapybusiness.industryHematologyMiddle Agedmedicine.diseaseGemcitabineGemcitabineSurgeryRegimenBile Duct NeoplasmsOncologyToxicityFemaleGallbladder NeoplasmsCisplatinbusinessProgressive diseasemedicine.drugAnnals of Oncology
researchProduct

Urothelial Leukoplakia: New Aspects of Etiology and Therapy

1987

AbstractWe describe 3 women in 1 family who had systemic urothelial leukoplakia with no underlying pathological condition of the urinary tract. Irritative clinical symptoms resolved, and the macroscopic and microscopic appearance improved after 6 months of therapy with sodium pentosan-polysulfate. Electron microscopy showed special cells in the basal layer of the cornified squamous epithelium that also have been found in the trigone of women with so-called squamous metaplasia. Their similarity to Merkel’s cells of the skin supports the theory that ectodermal cells are misplaced during embryogenesis. Genetic factors and sex hormones seem to influence the development of certain variants of sq…

AdultPathologymedicine.medical_specialtybusiness.industryUrologyUrinary systemUrinary BladderMiddle Agedmedicine.diseaseEpitheliumEpitheliumSquamous metaplasiaMicroscopy ElectronBasal (phylogenetics)medicine.anatomical_structureUrinary Bladder NeoplasmsEtiologyHumansMedicineTrigone of urinary bladderFemalebusinessPathologicalLeukoplakiaLeukoplakiaJournal of Urology
researchProduct

The sigma rectum pouch (Mainz pouch II)

1996

A low-pressure reservoir for urine is created by antimesenteric splitting and side-to-side anastomosis of the rectosigmoid, the expectation being to obtain better continence rates and better protection of the upper tract than are achievable by ureterosigmoidostomy. Between 1990 and August 1993 the procedure was performed in 73 patients (59 adults and 14 children) whose mean age was 43.5 years. The indications were malignancy (n = 55), bladder exstrophy/epispadias (n = 14), trauma (n = 3), and sinus urogenitalis (n = 1). Of the 73 patients, 69 were followed for a mean period of 127 (range, 1-34) months. In all, 5 early complications were encountered (6.8%). In addition, 8 late complications …

Adultmedicine.medical_specialtyEpispadiasAdolescentUrologymedicine.medical_treatmentEpispadiasAnastomosisSurgical anastomosisUreterosigmoidostomyPostoperative ComplicationsUreterColon SigmoidmedicineHumansChildAgedbusiness.industryPatient SelectionBladder ExstrophyUrinary Reservoirs ContinentRectumInfantSigmoid colonMiddle AgedPrognosismedicine.diseaseSurgeryBladder exstrophymedicine.anatomical_structureUrinary Bladder NeoplasmsChild PreschoolPouchbusinessFollow-Up StudiesWorld Journal of Urology
researchProduct